AIMS/HYPOTHESIS: Evidence has suggested that low serum potassium concentrations decrease insulin secretion, leading to glucose intolerance, and that hypokalaemia induced by diuretics increases the risk for diabetes in hypertensive individuals. However, no prospective study has investigated the association between serum potassium and the development of type 2 diabetes in a healthy cohort comprised of Asian individuals not being administered antihypertensive medications. This study aimed to investigate whether low serum potassium is associated with increased risk of type 2 diabetes in apparently healthy Japanese men. METHODS: We followed 4,409 Japanese men with no history of diabetes, use of antihypertensives, renal dysfunction or liver dysfunction (mean ± SD age, 48.4 ± 8.4 years). Cox proportional hazards regression was used to estimate HRs for incident diabetes (fasting plasma glucose level ≥ 7.0 mmol/l, HbA(1c) ≥ 6.5% or self-reported) including serum potassium concentration as either a categorical or a continuous variable. RESULTS: During a 5 year follow-up, 250 individuals developed type 2 diabetes. The lowest tertile of serum potassium (2.8-3.9 mmol/l) was independently associated with the development of diabetes after adjustment for known predictors (HR 1.57 [95% CI, 1.15-2.15]) compared with the highest tertile (4.2-5.4 mmol/l). Every 0.5 mmol/l lower increment in the baseline serum potassium level was associated with a 45% (12-87%) increased risk of diabetes. CONCLUSIONS/ INTERPRETATION: Mild to moderately low serum potassium levels, within the normal range and without frank hypokalaemia, could be predictive of type 2 diabetes in apparently healthy Japanese men.
AIMS/HYPOTHESIS: Evidence has suggested that low serum potassium concentrations decrease insulin secretion, leading to glucose intolerance, and that hypokalaemia induced by diuretics increases the risk for diabetes in hypertensive individuals. However, no prospective study has investigated the association between serum potassium and the development of type 2 diabetes in a healthy cohort comprised of Asian individuals not being administered antihypertensive medications. This study aimed to investigate whether low serum potassium is associated with increased risk of type 2 diabetes in apparently healthy Japanese men. METHODS: We followed 4,409 Japanese men with no history of diabetes, use of antihypertensives, renal dysfunction or liver dysfunction (mean ± SD age, 48.4 ± 8.4 years). Cox proportional hazards regression was used to estimate HRs for incident diabetes (fasting plasma glucose level ≥ 7.0 mmol/l, HbA(1c) ≥ 6.5% or self-reported) including serum potassium concentration as either a categorical or a continuous variable. RESULTS: During a 5 year follow-up, 250 individuals developed type 2 diabetes. The lowest tertile of serum potassium (2.8-3.9 mmol/l) was independently associated with the development of diabetes after adjustment for known predictors (HR 1.57 [95% CI, 1.15-2.15]) compared with the highest tertile (4.2-5.4 mmol/l). Every 0.5 mmol/l lower increment in the baseline serum potassium level was associated with a 45% (12-87%) increased risk of diabetes. CONCLUSIONS/ INTERPRETATION: Mild to moderately low serum potassium levels, within the normal range and without frank hypokalaemia, could be predictive of type 2 diabetes in apparently healthy Japanese men.
Authors: Ranee Chatterjee; Hsin-Chieh Yeh; Tariq Shafi; Elizabeth Selvin; Cheryl Anderson; James S Pankow; Edgar Miller; Frederick Brancati Journal: Arch Intern Med Date: 2010-10-25
Authors: Ranee Chatterjee; Clemontina A Davenport; Laura P Svetkey; Bryan C Batch; Pao-Hwa Lin; Vasan S Ramachandran; Ervin R Fox; Jane Harman; Hsin-Chieh Yeh; Elizabeth Selvin; Adolfo Correa; Kenneth Butler; David Edelman Journal: Am J Clin Nutr Date: 2016-12-14 Impact factor: 7.045
Authors: Ranee Chatterjee; Laine Thomas; Laura Svetkey; Frederick L Brancati; Robert M Califf; David Edelman Journal: Am J Hypertens Date: 2013-02-15 Impact factor: 2.689
Authors: Ranee Chatterjee; Cris Slentz; Clemontina A Davenport; Johanna Johnson; Pao-Hwa Lin; Michael Muehlbauer; David D'Alessio; Laura P Svetkey; David Edelman Journal: Am J Clin Nutr Date: 2017-11-01 Impact factor: 7.045
Authors: R Chatterjee; L A Colangelo; H C Yeh; C A Anderson; M L Daviglus; K Liu; F L Brancati Journal: Diabetologia Date: 2012-02-10 Impact factor: 10.122
Authors: Ranee Chatterjee; Mary L Biggs; Ian H de Boer; Frederick L Brancati; Laura P Svetkey; Joshua Barzilay; Luc Djoussé; Joachim H Ix; Jorge R Kizer; David S Siscovick; Dariush Mozaffarian; David Edelman; Kenneth J Mukamal Journal: J Gerontol A Biol Sci Med Sci Date: 2014-06-03 Impact factor: 6.053
Authors: Ranee Chatterjee; Frederick L Brancati; Tariq Shafi; David Edelman; James S Pankow; Thomas H Mosley; Elizabeth Selvin; Hsin Chieh Yeh Journal: J Gen Intern Med Date: 2013-08-14 Impact factor: 5.128
Authors: C Meisinger; D Stöckl; I M Rückert; A Döring; B Thorand; M Heier; C Huth; P Belcredi; B Kowall; W Rathmann Journal: Diabetologia Date: 2012-11-25 Impact factor: 10.122